News 

We are glad to have brought the VIROMARKERS project to the European Association for the Study of the Liver Congress (EASL 2026), held in Barcelona, Spain from 27 to 30 May 2026. The congress was a valuable opportunity to present our recent research and engage with the scientific community working in liver disease. It also provided a clear view of how current studies are evolving and how our work fits within the broader direction of the field. We are ready to continue our acti

The VIROMARKERS team proudly brought the project to the Italian Conference on AIDS and Antiviral Research (ICAR 2026), held in Catania, Italy from 20 to 22 May 2026. Here the conference website: https://www.icar2026.com/index.php A great opportunity to present the project, share and discuss innovation and connect with the scientific community working on HIV and antiviral research! We are also proud to announce that two contributions were selected among the finalists for Best

On 24–25 April, we gathered in Cologne, Germany for AREVIR 2026! The programme featured a dedicated EuCARE/VIROMARKERS session on 24 April, bringing together project partners for presentations and in-depth discussion within the broader meeting framework. These moments are key to keeping the consortium aligned beyond formal reporting lines, allowing perspectives to converge and ongoing work to be shaped collectively. Check below some of the key moments and the Agenda. AGENDA G

Today EuResist Network GEIE took part in the Innovative Health Initiative (IHI) Coordinator Training Day in Brussels. The session offered a great opportunity to exchange on financial and administrative management, reporting practices and common challenges across IHI projects. A useful moment to align, learn and bring back practical insights to support the ongoing work of VIROMARKERS !

On the occasion of World Health Day , the Innovative Health Initiative (IHI) has highlighted the work of VIROMARKERS as part of its “Together for Health, Stand with Science” message. The piece also includes the perspective of Francesca Incardona (EuResist Network) , Project Coordinator of VIROMARKERS , reflecting the value of public-private partnership in fostering collaboration and impactful science. “By connecting science, clinical expertise and industry, VIROMARKERS high

From 22 to 25 February 2026, members of the VIROMARKERS consortium, including University of Rome Tor Vergata, ASST Santi Paolo e Carlo, University of Cologne and MIB GmbH, attended the Conference on Retroviruses and Opportunistic Infections 2026 in Denver. During the conference, a VIROMARKERS-related study was presented in the lecture “Characterization of mutations outside the integrase in HIV-1 individuals in whom Dolutegravir failed” by Aurélie Minelle Kengni Ngueko from

Many Viromarkers partners in Barcelona for the 23rd European Meeting on HIV & Hepatitis ! Amongst them were EuResist, the University of...

EuResist, the University of Siena, the University of Rome Tor Vergata, and ASST Santi Paolo e Carlo, all members of the Viromarkers...

Viromarkers had a dedicated session, in collaboration with EuCARE , at this year’s AREVIR meeting! Amongst our speakers were Francesca...